Skip to content

Exploring the Impact of Biopsy Techniques and Surgical Wait Time on Early Breast Cancer Prognosis

Exploring the Impact of Biopsy Techniques and Surgical Wait Time on Early Breast Cancer Prognosis: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075857
Enrollment
Unknown
Registered
2023-09-18
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

patients with preoperative biopsy:Not applicable.

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with invasive ductal carcinoma who underwent preoperative biopsy; 2. Patients with AJCC stage T1-2N0-1 at initial diagnosis; 3. Patients with unilateral breast cancer.

Exclusion criteria

Exclusion criteria: 1. Patients without preoperative biopsy; 2. Patients with preoperative neoadjuvant chemotherapy, or breast cancer with uncertain initial clinical/pathologic staging; 3. Patients undergoing multiple biopsy methods at the same time; 4. Patients with AJCC stage pT3 or pN2-3 or M1 at initial diagnosis; 5. Patients with bilateral breast cancer at initial diagnosis or late follow-up.

Design outcomes

Primary

MeasureTime frame
Overall Survival;

Secondary

MeasureTime frame
Disease Free Survival;

Countries

China

Contacts

Public ContactGang Liu

Cancer Hospital, Chinese Academy of Medical Sciences

pumcliugang@163.com+86 132 6156 2520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026